Background: Trigger finger is a common hand disorder that limits finger range of motion and causes pain and snapping of the affected finger. Trigger finger is caused by an imbalance of the tendon sheath and the flexor tendon. The initial treatment is generally a local corticosteroid injection around the first annular (A1) pulley. However, it is not unusual that surgical release of the A1 pulley is required. Moreover, adverse events after local corticosteroid injection or operative treatment may occur. Platelet-rich plasma (PRP) has been shown to be safe and to reduce symptoms in different tendon pathologies, such as DeQuervain's disease. However, the effects of PRP on trigger finger have not been studied. The aim of this single-center triple-blind randomized controlled trial is to study whether PRP is non-inferior to corticosteroid injection in treating trigger finger. The secondary outcome is to assess the safety and efficacy of PRP in comparison to placebo.

Methods: The trial is designed as a randomized, controlled, patient-, investigator-, and outcome assessor-blinded, single-center, three-armed 1:1:1 non-inferiority trial. The patients with clinical symptoms of trigger finger will be randomly assigned to treatment with PRP, corticosteroid, or normal saline injection. The primary outcome is Patient-Rated Wrist Evaluation and symptom resolution. Secondary outcomes include Quick-Disabilities of the Arm, Shoulder and Hand; pain; grip strength; finger active range of motion; and complications. Appropriate statistical methods will be applied.

Discussion: We present a novel RCT study design on the use of PRP for the treatment of trigger finger compared to corticosteroid and normal saline injection. The results of the trial will indicate if PRP is appropriate for the treatment of trigger finger.

Trial Registration: ClinicalTrials.gov NCT04167098 . Registered on November 18, 2019.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7694424PMC
http://dx.doi.org/10.1186/s13063-020-04907-wDOI Listing

Publication Analysis

Top Keywords

trigger finger
28
corticosteroid injection
16
treatment trigger
12
finger
10
platelet-rich plasma
8
trigger
8
range motion
8
local corticosteroid
8
randomized controlled
8
corticosteroid normal
8

Similar Publications

Ultrasound-guided trigger thumb release.

Hand Surg Rehabil

January 2025

CHU de Nîmes, avenue du Pr Debré, 30000 Nîmes, France.

The purpose of this study was to evaluate the results of a novel retrograde ultrasound-guided A1 pulley release technique for the treatment of trigger thumb. We conducted a retrospective, single-center study of 42 patients who underwent ultrasound-guided A1 pulley release for clinically diagnosed trigger thumb between September 2022 and December 2023. All cases were graded according to the Green classification of trigger finger severity.

View Article and Find Full Text PDF

Carpal Tunnel, Trigger Finger, and Spinal Stenosis: The Rest of the Story.

S D Med

November 2024

Sanford Orthopedics and Sports Medicine, Sioux Falls, South Dakota.

Amyloidosis is a deadly systemic disease in which misfolded proteins accumulate in human tissue eventually leading to morbid dysfunction in multiple organ systems. The prognosis of untreated amyloidosis is poor. Orthopedic manifestations of amyloidosis include carpal tunnel syndrome (CTS), trigger digit, distal biceps tendon rupture, rotator cuff disease, and lumbar spinal stenosis.

View Article and Find Full Text PDF

A collaborative interdisciplinary approach for trigger finger management.

J Hand Ther

January 2025

Venture Rehabilitation Sciences Group, Saskatoon, SK, Canada; School of Rehabilitation Science, University of Saskatchewan, Saskatoon, SK, Canada. Electronic address:

Background: Stenosing tenosynovitis, or trigger finger, is a common cause of hand disability. This study outlines a trigger finger management protocol that redirects referrals for surgical consultations to conservative management first.

Purpose: The primary outcome variable was the protocol endpoint based on the resolution of trigger finger symptoms (i.

View Article and Find Full Text PDF

ASSESSMENT OF SATISFACTION IN PATIENTS UNDERGOING SURGICAL TREATMENT BY THE WALANT TECHNIQUE.

Acta Ortop Bras

January 2025

Santa Casa de Misericórdia de Sao Paulo, Pavilhão "Fernandinho Simonsen", Especialização em Mao e Microcirurgia, Sao Paulo, SP, Brazil.

Objective: To analyze the satisfaction of patients who underwent hand surgical treatment with the wide-awake local anesthesia no tourniquet (WALANT) anesthesia technique.

Methods: This is a cross-sectional study on the satisfaction of patients who underwent hand surgical treatment with the WALANT technique. These patients were treated at the Hand and Microsurgery outpatient clinic of a public hospital from March 2020 to March 2022.

View Article and Find Full Text PDF

Ultrasound-guided trigger finger release with a minimally invasive knife: A retrospective analysis of 297 releases.

Hand Surg Rehabil

January 2025

Chirurgie de la Main et de la Membre supérieur, Médipôle 1 rue Jules Méline, 51430 Bezannes, France.

Trigger finger, or stenosing tenovaginitis, is a common condition characterized by impaired flexor tendon sliding due to thickening of the A1 pulley. While open surgical release remains the gold standard for the treatment of persistent trigger finger, there is increasing interest in minimally invasive ultrasound-guided techniques to improve precision and outcomes. The purpose of this study is to evaluate the outcomes, safety, and complications associated with ultrasound-guided trigger finger release using a minimally invasive surgical knife.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!